Hanyu Pharmaceutical (300199.SZ) released its first quarter results, turning a loss into a profit of 69.86 million yuan.

Zhijing Finance APP News, Han Yu Pharmaceutical (300199.SZ) released its first quarter report for 2025, with the company's operating income reaching 310 million yuan, a year-on-year increase of 106.29%. The net profit attributable to the shareholders of the listed company was 69.8684 million yuan. The net profit attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 65.55 million yuan. The basic earnings per share were 0.08 yuan.